C. Elizabeth Caldon

Cited by

	All	Since 2016
Citations	4498	2706
h-index	29	23
i10-index	38	35

560

280

140

420

2002200320042005200620072008200920102011201220132014201520162017201820192020202114 11 39 41 54 78 103 136 125 122 208 266 257 309 427 475 463 423 552 363

Public access

View all

17 articles

0 articles

available

not available

Based on funding mandates

Co-authors

Andrew BurgessAnzac Research Institute, NSW, AustraliaVerified email at anzac.edu.au
Samuel RogersChildren's Medical Research InstituteVerified email at cmri.org.au
ormandy cjVerified email at garvan.org.au
Andrew StoneCardiff University, Garvan Institute, Children's Cancer InstituteVerified email at ccia.org.au
Rachael McCloyThe Kinghorn Cancer Centre, Garvan Institute of Medical ResearchVerified email at garvan.org.au
Alexander SwarbrickLaboratory Head, Garvan Institute of Medical Research | Co-Head, Breast Translational OncologyVerified email at garvan.org.au
Elgene LimUNSW, Garvan Institute, St Vincent's HospitalVerified email at garvan.org.au
Roger DalyDept of Biochemistry and Molecular Biology, Monash UniversityVerified email at monash.edu
David Gallego-OrtegaGarvan Institute of Medical ResearchVerified email at garvan.org.au
Neil PortmanGarvan Institute of Medical ResearchVerified email at garvan.org.au
susan j clarkprofessor Garvan institute of medical researchVerified email at garvan.org.au
Niantao DengGarvan Institue of Medical ResearchVerified email at garvan.org.au
Sandra O'TooleClinical Professor Sydney University and Staff Specialist Tissue Pathology Royal Prince Alfred HospitalVerified email at garvan.org.au
Anna CastroCRBM-CNRSVerified email at crbm.cnrs.fr
Neil HunterAssociate Dean (Research), Faculty of Dentistry, USyd; Director, Institute of Dental ResearchVerified email at sydney.edu.au
Alison ButtUNSWVerified email at unsw.edu.au
Kate GouldGarvan Institute of Medical ResearchVerified email at garvan.org.au
Clare StirzakerGarvan Institute of Medical ResearchVerified email at garvan.org.au
Phuc-Loi LuuPost-doc researcher at Garvan Institue of Medical Research, Sydney, AustraliaVerified email at garvan.org.au
Shalima S NairPostdoctoral Fellow at Garvan Institute of Medical ResearchVerified email at garvan.org.au

C. Elizabeth Caldon

Garvan Institute of Medical Research, Australia

Verified email at garvan.org.au

G1/S cell cycle hormone action CDK2 CDK4/6 inhibitors


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Cyclin D as a therapeutic target in cancer EA Musgrove, CE Caldon, J Barraclough, A Stone, RL Sutherland Nature Reviews Cancer 11 (8), 558-572, 2011	1213	2011
Partial inhibition of Cdk1 in G₂ phase overrides the SAC and decouples mitotic events RA McCloy, S Rogers, CE Caldon, T Lorca, A Castro, A Burgess Cell cycle 13 (9), 1400-1412, 2014	744	2014
Cell cycle control in breast cancer cells CE Caldon, RJ Daly, RL Sutherland, EA Musgrove Journal of cellular biochemistry 97 (2), 261-274, 2006	274	2006
Evolution of a molecular switch: universal bacterial GTPases regulate ribosome function CE Caldon, P Yoong, PE March Molecular microbiology 41 (2), 289-297, 2001	194	2001
Function of the universally conserved bacterial GTPases CE Caldon, PE March Current opinion in microbiology 6 (2), 135-139, 2003	135	2003
Estrogen signaling and the DNA damage response in hormone dependent breast cancers CE Caldon Frontiers in Oncology, 137, 2014	127	2014
Increased proliferation and altered growth factor dependence of human mammary epithelial cells overexpressing the Gab2 docking protein T Brummer, D Schramek, VM Hayes, HL Bennett, CE Caldon, ... Journal of Biological Chemistry 281 (1), 626-637, 2006	126	2006
Distinct and redundant functions of cyclin E1 and cyclin E2 in development and cancer CE Caldon, EA Musgrove Cell division 5 (1), 1-13, 2010	118	2010
Cyclin E2 overexpression is associated with endocrine resistance but not insensitivity to CDK2 inhibition in human breast cancer cells CE Caldon, CM Sergio, J Kang, A Muthukaruppan, MN Boersma, A Stone, ... Molecular cancer therapeutics 11 (7), 1488-1499, 2012	109	2012
Identification of functional networks of estrogen-and c-Myc-responsive genes and their relationship to response to tamoxifen therapy in breast cancer EA Musgrove, CM Sergio, S Loi, CK Inman, LR Anderson, MC Alles, ... PloS one 3 (8), e2987, 2008	109	2008
Regulation of cyclin expression and cell cycle progression in breast epithelial cells by the helix–loop–helix protein Id1 A Swarbrick, MC Åkerfeldt, CSL Lee, CM Sergio, CE Caldon, LJK Hunter, ... Oncogene 24 (3), 381-389, 2005	95	2005
Cell cycle proteins in epithelial cell differentiation: implications for breast cancer CE Caldon, RL Sutherland, EA Musgrove Cell cycle 9 (10), 1918-1928, 2010	87	2010
Functional interaction of 13 yeast SCF complexes with a set of yeast E2 enzymes in vitro BM Kus, CE Caldon, R Andorn‐Broza, AM Edwards Proteins: Structure, Function, and Bioinformatics 54 (3), 455-467, 2003	86	2003
ELF5 suppresses estrogen sensitivity and underpins the acquisition of antiestrogen resistance in luminal breast cancer M Kalyuga, D Gallego-Ortega, HJ Lee, DL Roden, MJ Cowley, CE Caldon, ... PLoS biology 10 (12), e1001461, 2012	84	2012
Cell Cycle Machinery AJ Butt, CE Caldon, CM McNeil, A Swarbrick, EA Musgrove, ... Innovative endocrinology of cancer, 189-205, 2008	75	2008
Estrogen regulation of cyclin E2 requires cyclin D1 but not c-Myc CE Caldon, CM Sergio, J Schütte, MN Boersma, RL Sutherland, ... Molecular and cellular biology 29 (17), 4623-4639, 2009	71	2009
Cyclin-dependent kinase 2 inhibitors in cancer therapy: an update S Tadesse, EC Caldon, W Tilley, S Wang Journal of medicinal chemistry 62 (9), 4233-4251, 2018	68	2018
Carious Dentine Provides a Habitat for a Complex Array of Novel Prevotella-Like Bacteria MA Nadkarni, CE Caldon, KL Chhour, IP Fisher, FE Martin, NA Jacques, ... Journal of clinical microbiology 42 (11), 5238-5244, 2004	61	2004
Porphyrin-Mediated Cell Surface Heme Capture from Hemoglobin by Porphyromonas gingivalis M Paramaesvaran, KA Nguyen, E Caldon, JA McDonald, S Najdi, ... Journal of bacteriology 185 (8), 2528-2537, 2003	58	2003
Overcoming CDK4/6 inhibitor resistance in ER-positive breast cancer N Portman, S Alexandrou, E Carson, S Wang, E Lim, CE Caldon Endocrine-related cancer 26 (1), R15-R30, 2019	56	2019

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow this author

Cited by

Co-authors